Jiangbo Pharmaceuticals Receives Approval for Felodipine Sustained Release Tablets
LAIYANG, China, June 10 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) (the "Company" or "Jiangbo"), today announced that the Company received approval from the Chinese State Food and Drug Administration ("SFDA") to start producing Felodipine sustained release ("SR")...
Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market
LAIYANG, China, June 4 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that the Company has received approval to list its common stock on the NASDAQ Global...
Jiangbo Pharmaceuticals Reports Results for Third Quarter of Fiscal Year 2010
LAIYANG, China, May 17 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China, today announced financial results for the third quarter fiscal year 2010 en...
Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Third Quarter Fiscal 2010
LAIYANG, China, May 14 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that the Company will host a conference call at 7:00 a.m. Eastern Time on Monday, Ma...
Jiangbo Pharmaceuticals to Attend CCG China Rising Investment Conference and BMC 2010 Life Sciences Summit
LAIYANG, China, May 14 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), today announced that Ms. Elsa Sung, the Company's Chief Financial Officer, will participate in the upcoming CCG China Rising Investment Conference and Brean Murray, ...
Jiangbo Pharmaceuticals Announced Amendment to the October 2009 Land Contract Eliminating Standard Investment Requirements
LAIYANG, China, April 13 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), today announced that Laiyang Jiangbo Pharmaceuticals, Co., Ltd., the Company's operating entity in China, has recently entered into an amended agreem...
Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
LAIYANG, China, Feb. 23 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China, today announced its financial results for the second quarter...
Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
LAIYANG, China, Feb. 23 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that the Company will host a conference call at 8:30 a.m. Eastern on Friday, Februa...
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Directory
LAIYANG, China, Jan. 13 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that its Osteomyelitis treatment tablets (Kang Gu Sui Yan Pian) has been included i...
Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
LAIYANG, China, Jan. 12 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that one of its factories in China obtained a renewal of its Good Manufacturing...
Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
LAIYANG, China, Nov. 18 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China, today announced its financial results for its first quarter ...
Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
LAIYANG, China, Nov. 16 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc., (OTC Bulletin Board: JGBO; "Jiangbo" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that the Company will host a conference c...
Jiangbo Pharmaceuticals to Present at Brean Murray, Carret 2009 China Growth Conference
LAIYANG, China, Nov. 13 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that the Company's management will present at the upcoming Brean Murray, ...
Jiangbo Pharmaceuticals Announces Resignation of Chief Operating Officer
LAIYANG, China, Oct. 23 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced the resignation of Mr. Haibo Xu, the Company's Chief Operating Officer ("COO"), eff...
Jiangbo Pharmaceuticals Announces Record Fourth Quarter and Fiscal Year 2009 Results
LAIYANG, China, Sept. 29 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China, today announced financial results for its fourth quarter an...
Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2009 Results
LAIYANG, China, Sept. 26 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc., (OTC Bulletin Board: JGBO; "Jiangbo" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that the Company will host a conference call at 9:00...
Jiangbo Pharmaceuticals Reaffirms Guidance for Fiscal 2009
LAIYANG, China, Sept. 8 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company", "Jiangbo"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today reaffirmed its previously announced guidance for fiscal year 2009...
Jiangbo Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
LAIYANG, China, Sept. 2 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company", "Jiangbo"), a U.S. pharmaceutical company with its principal operations in the People’s Republic of China, today announced that Ms. Elsa Sung, the Company’s CFO will present at t...
Jiangbo Pharmaceuticals to Attend the 44th China New Drugs Trade Fair in Tianjin
Company to Launch Promotional Campaign for Laiyang Pear Cough Syrup LAIYANG, China, June 18 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: JGBO) (the "Company", "Jiangbo"), a U.S. pharmaceutical company with its principal operations in the People...
Jiangbo Pharmaceuticals Reports Results for the Third Quarter of its Fiscal Year 2009
LAIYANG, China, May 18 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (“Jiangbo” or the “Company”), a U.S. pharmaceutical company with its principal operations in the People’s Republic of China, today announced its financial results for the third quarter ended Marc...
